@article{e95da0641e46498787bdab2c6f62b77e,
title = "A Multicenter, Open-label, Clinical Trial to Assess the Effectiveness and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-intensity Conditioning in Relapsed/refractory Anaplastic Large-cell Lymphoma in Children",
abstract = "No standard treatment for relapsed or refractory anaplastic large-cell lymphoma (ALCL) has been established. This study is a multicenter, open-label trial to examine the effectiveness and safety of transplantation with reduced-intensity conditioning (RIC) for patients under 20 years old with relapsed or refractory ALCL. We defined RIC as the administration of fludarabine (30 mg/mx2/day) for five days plus melphalan (70 mg/mx2/day) for two days and total body irradiation at 4 Gy, followed by allogeneic hematopoietic stem cell transplantation.",
author = "Akiko Kada and Reiji Fukano and Tetsuya Mori and Michi Kamei and Fumiko Tanaka and Junichi Ueyama and Masahiro Sekimizu and Tomoo Osumi and Takeshi Mori and Yuhki Koga and Kentaro Ohki and Naoto Fujita and Tetsuo Mitsui and Saito, {Akiko M.} and Hiroya Hashimoto and Ryoji Kobayashi",
note = "Funding Information: Acknowledgments. This study is supported by a grant from Yamaguchi University Graduate School of Medicine and the Japan Agency for Medical Research and Development (19ck0106434h0002). Publisher Copyright: {\textcopyright} 2020 by Okayama University Medical School.",
year = "2020",
language = "English",
volume = "74",
pages = "89--94",
journal = "Acta medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "1",
}